Delgado-Corcoran Claudia, Bodily Stephanie, Frank Deborah U, Witte Madolin K, Castillo Ramon, Bratton Susan L
1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Primary Children's Hospital, University of Utah, Salt Lake City, UT. 2Department of Systems Improvement, Primary Children's Hospital, Salt Lake City, UT.
Pediatr Crit Care Med. 2014 Oct;15(8):756-61. doi: 10.1097/PCC.0000000000000194.
To safely optimize blood testing and costs for pediatric cardiac surgical patients without adversely impacting patient outcomes.
This is a quality improvement cohort project with pre- and postintervention groups.
University-affiliated pediatric cardiac ICU in a tertiary care children's hospital.
All patients were surgical patients for whom Risk Adjustment for Congenital Heart Surgery categories allowed for stratification by complexity. The preintervention group was treated in 2010 and the postintervention group in 2011.
Laboratory ordering processes were analyzed, and practice changed to limit standing blood test orders and requires individualized ordering.
Three hundred nineteen patients were studied in 2010 and 345 in 2011. Groups were similar in median age, weight, length of stay (ICU length of stay), and Risk Adjustment for Congenital Heart Surgery category. There was a reduction in the total blood tests per patient (24 vs 38; p < 0.0001) and length of stay adjusted tests per patient-day (10.4 vs 14.4; p = 0.0001) in the postintervention group. The largest test reductions were blood gases and single electrolytes. Adverse outcomes, such as extubation failure (6.4% vs 5.6%), central catheter-associated bloodstream infection (2.2 vs 1.5), and hospital mortality (0.6% vs 0.6%), were not significantly different between the groups. Cost analysis demonstrated an overall laboratory cost savings of 32%. In addition, the volume of packed RBC transfusions was also significantly decreased in the postintervention group among the most complex patients (Risk Adjustment for Congenital Heart Surgery, 6).
Blood testing rates were safely decreased in postoperative pediatric cardiac patients by changing laboratory ordering practices. In addition, packed RBC transfusion was decreased among the most complex patients.
在不影响患儿手术结果的前提下,安全地优化小儿心脏手术患者的血液检测并降低成本。
这是一个有干预前和干预后组别的质量改进队列项目。
一家三级儿童医院的大学附属小儿心脏重症监护病房。
所有患者均为接受先天性心脏病手术的患者,根据先天性心脏病手术风险调整分类可按复杂程度分层。干预前组于2010年接受治疗,干预后组于2011年接受治疗。
分析实验室医嘱流程,并改变做法以限制常规血液检测医嘱并要求个体化医嘱。
2010年研究了319例患者,2011年研究了345例患者。两组在中位年龄、体重、住院时间(重症监护病房住院时间)和先天性心脏病手术风险调整分类方面相似。干预后组患者的人均血液检测总量减少(24次对38次;p<0.0001),人均每日住院时间调整后的检测次数减少(10.4次对14.4次;p = 0.0001)。检测次数减少最多的是血气和单项电解质检测。两组之间的不良结局,如拔管失败(6.4%对5.6%)、中心导管相关血流感染(2.2对1.5)和医院死亡率(0.6%对0.6%),无显著差异。成本分析表明实验室总成本节省了32%。此外,在最复杂的患者(先天性心脏病手术风险调整分类为6)中,干预后组的浓缩红细胞输注量也显著减少。
通过改变实验室医嘱做法,小儿心脏术后患者的血液检测率得以安全降低。此外,最复杂的患者中浓缩红细胞输注量也减少了。